Biologics and the Changing Landscape of Pharmacology Education: A Call for Curricular Transformation

Abstract

The emergence of biologics—complex therapeutics derived from living systems—has transformed the pharmaceutical and clinical landscape, challenging the traditional small-molecule-focused paradigm of pharmacology education. This paper examines the scientific, economic, and educational implications of biologics and highlights the widening disconnect between current pharmacology curricula and contemporary therapeutic practices. Drawing on global examples from leading institutions such as Harvard, UCSF, Melbourne, AIIMS, and Kyoto University, we demonstrate how pharmacology education is being reframed through interdisciplinary integration, problem-based learning, and translational science. In contrast, many curricula in developing regions remain stagnant, inadequately preparing graduates for roles in biologics regulation, pharmacovigilance, and molecular therapeutics. We propose a strategic framework for curricular reform that includes integrating molecular sciences, revising departmental nomenclature, fostering cross-disciplinary collaboration, and embedding ethical and economic literacy. Addressing these gaps is essential to equipping future pharmacologists and clinicians for the complex challenges of 21st-century medicine.

How to cite this article:
Kaluarachchi K, Biologics And The Changing Landscape Of Pharmacology Education: A Call For Curricular Transformation. IAP J. Med. Educ. Res. 2025;2(2):2-4.